 Nuwellis

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Nuwellis reports revenue growth and margin improvement in Q1 2024

Nuwellis' Q1 2024 performance showed revenue growth driven by consumable utilization, improved margins, and reduced operating losses. Challenges in critical care revenue persist, but expense reductions and growth opportunities in pediatrics signal a positive outlook.

Nuwellis reports revenue growth and operational improvements in Q2 2024

Nuwellis (NUWE) showed improved financial performance in Q2 2024 with revenue growth and reduced operating loss, despite challenges in the pediatric segment.
The company's strengths lie in successful product launches, financial stability, and increasing market presence, while facing challenges in pediatric revenue and R&D expenses.
Opportunities for Nuwellis include leveraging positive momentum, expanding product adoption, and capitalizing on its strong financial position for future growth.

Nuwellis reports Q3 revenue decline but operational improvements signal growth

Nuwellis showed mixed financial performance in Q3 2024 with revenue decline but operational improvements and net income.
The company faces challenges in certain product categories but benefits from growth opportunities like increased reimbursement rates.
Strategic decisions like terminating agreements and raising funds position Nuwellis for future growth and market competitiveness.
Overall, Nuwellis is navigating a dynamic market landscape with a focus on product effectiveness and financial sustainability.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Nuwellis, Inc. (NUWE) CEO Nestor Jaramillo on Q3 2021 Results - Earnings Call Transcript

MINNEAPOLIS, Nov. 09, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the third quarter ended September 30, 2021, which included the following highlights:

Nuwellis, Inc. Announces Third Quarter 2021 Financial Results

EDEN PRAIRIE, Minn., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE) was honored at the 2021 R&D 100 Awards last month, with its Aquadex SmartFlow® system selected as a winner in the Analytical/Test category. The awards, presented by R&D World, recognize commercial products, technologies and materials for their technological significance that are available for sale or license. This renowned worldwide competition is its 59th year and received entries from 17 countries/regions. This year, the judging panel included nearly 40 well-respected industry professionals from across the globe.

Aquadex SmartFlow® System by Nuwellis Selected as a 2021 R&D 100 Awards Winner

EDEN PRAIRIE, Minn., Oct. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its third quarter 2021 financial results will be released on Tuesday, November 9, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.

Nuwellis, Inc. To Announce Third Quarter 2021 Financial Results on November 9, 2021

Nuwellis Inc (NASDAQ:NUWE) has received CE Mark Certification for its 24-Hour Blood Circuit Set (UF 500-24 Hour) for the European Union. The UF 500-24 Hour blood circuit set is only to be used with the company's Aquadex SmartFlow system.

Nuwellis Stock Is Moving Higher After CE Mark for 24-Hour Blood Circuit Set

Certification will help Nuwellis meet clinical and healthcare economic needs in Europe and make outpatient ultrafiltration treatment more accessible Certification will help Nuwellis meet clinical and healthcare economic needs in Europe and make outpatient ultrafiltration treatment more accessible

Nuwellis Receives CE Mark for 24-Hour Blood Circuit Set

EDEN PRAIRIE, Minn., Sept. 17, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the closing of its previously announced underwritten public offering of 4,005,588 shares of its common stock at a price to the public of $2.50 per share, for gross proceeds of approximately $10.0 million, including the full exercise of the underwriters' over-allotment option to purchase additional shares of the Company's common stock, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company.

Nuwellis, Inc. Announces Closing of $10.0 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

Nuwellis (NASDAQ:NUWE) shares are trading lower after the company announced it priced a 3,483,120 share common stock offering at $2.50 per share. Nuwellis' stock has been falling Wednesday, down 28.46% to a price of $2.64.

Why Nuwellis Shares Are Trading Lower Today

EDEN PRAIRIE, Minn., Sept. 15, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the pricing of an underwritten public offering of 3,483,120 shares of its common stock at a price to the public of $2.50 per share, for gross proceeds of approximately $8.7 million prior to deducting underwriting discounts and commissions and offering expenses payable by the Company.  The Company has granted the underwriters an option, exercisable in whole or in part for 45 days, to purchase up to an additional 522,468 shares of its common stock at the public offering price, less the underwriting discounts and commissions.

Nuwellis, Inc. Announces Pricing of $8.7 Million Underwritten Public Offering of Common Stock

EDEN PRAIRIE, Minn., Sept. 14, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today that it intends to offer shares of its common stock in an underwritten public offering.  All of the shares of common stock to be sold in the offering will be offered by the Company.  The Company intends to grant the underwriters a 45-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering.  The Company intends to use the net proceeds for the offering for general corporate purposes, including the continued investment in commercialization efforts. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Nuwellis, Inc. Announces Proposed Underwritten Public Offering of Common Stock

EDEN PRAIRIE, Minn., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, announced today that Nestor Jaramillo Jr., Chief Executive officer, and George Montague, Chief Financial Officer, are scheduled to participate virtually in following upcoming investor conferences.

Nuwellis Inc. to Speak at Upcoming Investor Conferences

Nuwellis, Inc. (NUWE) CEO Nestor Jaramillo on Q2 2021 Results - Earnings Call Transcript

EDEN PRAIRIE, Minn., Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) announced today its results for the second quarter ended June 30, 2021, which included the following highlights:

Nuwellis, Inc. Announces 35 Percent Increase in Revenue for Second Quarter 2021 Over Previous Year and Provides Company Update

EDEN PRAIRIE, Minn., July 27, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), announced today that its second quarter 2021 financial results will be released on Tuesday, August 10, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.

Nuwellis, Inc. To Announce Second Quarter 2021 Financial Results on August 10, 2021

EDEN PRAIRIE, Minn., July 06, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ: NUWE), a company focused on providing solutions for patients suffering from fluid overload, today announced that, Nestor Jaramillo, Chief Executive officer, and George Montague, Chief Financial Officer, are scheduled to participate in the 2021 Ladenburg Thalmann Healthcare Conference on Wednesday, July 14th, 2021.

Nuwellis Inc. to Participate at the 2021 Ladenburg Thalmann Healthcare Conference

George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer George Montague to serve as Chief Financial Officer and Neil P. Ayotte, to serve as General Counsel and Chief Compliance Officer

Nuwellis Announces New Appointments to Leadership Team

The stock price of Nuwellis Inc (NASDAQ: NUWE) increased by over 20% during intraday trading. This is why it happened.

NUWE Stock Price: Over 20% Increase Explanation

Nova Lifestyle

Rubicon Technology

Benjamin Graham believed buying stocks at a deep discount to the value of their assets was a great way to achieve reduced risk and profits in the long run.

3 Deep Value Benjamin Graham Style Stocks

Nuwellis, Inc. (NUWE) CEO Nestor Jaramillo on Q1 2021 Results - Earnings Call Transcript

Gentle Ultrafiltration with Aquadex SmartFlow® Expands Options for Pediatric Patients Gentle Ultrafiltration with Aquadex SmartFlow® Expands Options for Pediatric Patients

Nuwellis Provides More Children in Texas With Access to Its Unique Fluid Management Technology

CHF Solutions

EDEN PRAIRIE, Minn., May 11, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (previously CHF Solutions, Inc.) announced today its results for the first quarter ended March 31, 2021, which included the following highlights:

Nuwellis, Inc. Announces 18 Percent Increase in Revenue for First Quarter 2021 Over Previous Year and Provides Company Update

EDEN PRAIRIE, Minn., April 29, 2021 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), formally CHF Solutions, announces today that its first quarter 2021 financial results will be released on Tuesday, May 11, 2021. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company's financial results and provide a general business overview.

News for Nuwellis Stock (NUWE)